1. Miettinen M, Majidi M, Lasota J. Pathology and diagnostic
criteria of gastrointestinal stromal tumors: a
review. Eur J Cancer 2002; 38: 39-51.
2. Dizdar Ö, Güler N. Gastrointestinal stromal tümörler
ve imatinib tedavisi. Hacettepe Tıp Dergisi 2004; 35:
87-91.
3. Sturgeon C, Chejfec G, Espat N. Gastrointestinal stromal
tumors: a spectrum of diseases. Surg Oncol 2003;
12: 21-26.
Cerrahpafla Tıp Derg 2008; 39(1): 33-36
4. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF.
Gastrointestinal stromal tumors: Current diagnosis,
biologic behavior, and management. Ann Surg Oncol
2000; 7: 705-712.
5. Meester B, Pauwels PA, Dijnentcog AM, et al.
Metastasis in a benign duodenal stromal tumour. Eur
J Surg Oncol 1998; 24: 334-335.
6. Goh BK, Chow PK, Ong HS, Wong WK.
Gastrointestinal stromal tumor involving the second
and third portion of the duodenum: Treatment by partial
duodenectomy and Roux-en-Y duodenojejunostomy.
J Surg Oncol 2005; 4: 273-275.
7. Jeon SW, Park YD, Chung YJ, et al. Gastrointestinal
stromal tumors of the stomach: Endosonographic differentiation
in relation to histological risk. J
Gastroenterol Hepatol 2007; 22: 2069-2075.
8. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of
gastrointestinal stromal tumors: a consensus
approach. Hum Pathol 2002; 33: 459-645.
9. Gunawan B, Bergmann F, Hoer J, et al. Biological and
clinical significance of cytogenetic abnormalities in
low-risk and high-risk gastrointestinal stromal tumors.
Hum Pathol 2002; 33: 316-321.
10. Miettinen M, El Rifai W, HL Sobin L, et al. Evaluation
of malignancy and prognosis of gastrointestinal
tumors: a review. Hum Pathol 2002; 338: 478-483.
11. Perek S, Perek A, fiarman K, et al. Duedonal stromal
tümör. Cerrahpafla Tıp Dergisi 2007; 38: 102-105.
12. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T.
Clinicopathologic study of primary malignant gastrointestinal
stromal tumor of the stomach with special
reference to prognostic factors: analysis of results
in 140 surgically resected patients. Gastric Cancer
2003; 6: 39-48.
13. Roberts PJ, Eisenberg B. Clinical presentation of gastrointestinal
stromal tumors and treatment of operable
disease. Eur J Cancer 2002; 38: 37-38.
14. De Matteo RP, Lewis JJ, Leung D. Two hundred gastrointestinal
stromal tumors: recurrence patterns and
prognostic factors for survival. Ann Surg 2000; 231:
51-58.
15. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G.
Clinical management of gastrointestinal tumors before
and after STI-571. Hum Pathol 2002; 33: 466-477.
16. Joensuu H, Fletcher C, Dimitrijevic S, Silberman S,
Roberts P, Demetri G. Management of malignant gastrointestinal
stromal tumours. Lancet Oncol 2002; 3:
655-664.
17. van Den Abbeele AD, Badawi RD. Use of positron
emission tomography in oncology and its potential
role to assess response to imatinib mesylate therapy in
gastrointestinal stromal tumors. Eur J Cancer 2002;
38: 60-65.
Thank you for copying data from http://www.arastirmax.com
